Pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceutical companies ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- SAR 19.04T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | SAR 37.5B | SAR 248.09 | 5.47% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | SAR 30.9B | SAR 445.79 | 1.92% up | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | SAR 18B | SAR 319.96 | 1.93% down | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | SAR 31B | SAR 475.35 | 1.65% up | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | SAR 32.2B | SAR 1,153.75 | 0.83% up | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | SAR 27B | SAR 193.53 | 0.11% down | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | SAR 17.4B | SAR 104.43 | 3.26% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | SAR 22.4B | SAR 1,120.35 | 1.66% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | SAR 35.9B | SAR 378.29 | 7.50% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | SAR 29.4B | SAR 174.72 | 2.49% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | SAR 17.1B | SAR 155.87 | 1.15% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | SAR 56.9B | SAR 292.05 | 1.38% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | SAR 18B | SAR 51.35 | 1.44% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | SAR 18.3B | SAR 105.44 | 0.93% up | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | SAR 22.6B | SAR 345.71 | 0.23% up | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | SAR 18.2B | SAR 189.35 | 1.21% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | SAR 24.4B | SAR 359.94 | 0.38% down | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | SAR 18.9B | SAR 225.64 | 0.34% down | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | SAR 34.5B | SAR 1,486.30 | 6.10% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | SAR 59.3B | SAR 923.57 | 2.29% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | SAR 28B | SAR 255.39 | 2.83% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | SAR 23B | SAR 162.57 | 0.81% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | SAR 19.7B | SAR 467.64 | 0.77% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | SAR 44.6B | SAR 230.33 | 4.95% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | SAR 14.9B | SAR 108.65 | 1.41% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | SAR 50.4B | SAR 100.88 | 4.04% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | SAR 98.6B | SAR 449.63 | 1.63% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | SAR 105.1B | SAR 145.09 | 0.08% down | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | SAR 26.4B | SAR 502.52 | 1.46% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | SAR 11.8B | SAR 60.92 | 0.81% up | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | SAR 28B | SAR 356.74 | 0.01% down | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | SAR 31.5B | SAR 39.42 | 1.50% down | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | SAR 27.4B | SAR 313.43 | 1.78% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | SAR 66.7B | SAR 1,016.52 | 0.07% down | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | SAR 92.6B | SAR 2,175.39 | 0.71% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | SAR 131.9B | SAR 324.61 | 3.67% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | SAR 75.3B | SAR 561.99 | 4.27% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | SAR 23.8B | SAR 585.98 | 0.95% down | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | SAR 28.6B | SAR 82.03 | 3.55% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | SAR 87.8B | SAR 76.56 | 0.20% down | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | SAR 47B | SAR 56.32 | 1.52% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | SAR 184.3B | SAR 157.97 | 1.18% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | SAR 601.5B | SAR 105.53 | 1.18% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | SAR 459.7B | SAR 224.91 | 2.27% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | SAR 148.7B | SAR 258.69 | 0.41% up | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | SAR 367.6B | SAR 3,553.77 | 1.08% down | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | SAR 512.8B | SAR 2,022.40 | 0.93% up | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | SAR 118.4B | SAR 192.09 | 1.44% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | SAR 173.2B | SAR 1,515.93 | 2.21% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | SAR 682.2B | SAR 393.91 | 0.29% up | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | SAR 1.28T | SAR 518.99 | 3.49% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | SAR 1.9T | SAR 1,075.39 | 2.09% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | SAR 21.6B | SAR 31.71 | 2.03% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | SAR 652.4B | SAR 148.03 | 3.03% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | SAR 4.64T | SAR 5,206.26 | 1.95% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | SAR 366.5B | SAR 182.82 | 1.02% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | SAR 2.47T | SAR 1,027.16 | 1.75% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | SAR 425B | SAR 177.01 | 0.72% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | SAR 1.1T | SAR 582.62 | 2.39% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | SAR 1.04T | SAR 671.88 | 1.73% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | SAR 255.1B | SAR 79.84 | 1.64% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which pharmaceutical companies rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceutical companies ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by short interest have a combined market value of SAR 19.04T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.